| Financial Year |
March 31 2023 |
| Monetary Funds |
453,627,876.44 |
| Held-for-trading Financial Assets |
813,431,357.99 |
| Notes Receivable |
-- |
| Accounts Receivable |
754,841,361.16 |
| Advances to Suppliers |
271.40 |
| Other Receivables |
6,263,327.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
502,945.20 |
| Dividend Receivable |
-- |
| Inventories |
7,949,398.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
544,565,068.49 |
| Other Current Assets |
-- |
| Total Current Assets |
2,580,678,661.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
688,511,245.68 |
| Investment Properties |
84,685,333.02 |
| Fixed Assetes |
13,049,470,327.24 |
| Under-construction Projects |
166,259,426.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
295,862,680.62 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
805,082,435.90 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
22,252,851,617.76 |
| Total Assets |
24,833,530,279.26 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
12,306,309.49 |
| Accounts Received In Advance |
17,768,041.52 |
| Employee Compensation Payable |
317,739,203.60 |
| Taxes Payable |
68,197,526.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,931,477,514.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
209,806,121.30 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
3,566,221,764.84 |
| Long-term Loans |
4,274,290,990.31 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,597,929.38 |
| Deferred Income Tax Liabilities |
16,127,054.79 |
| Other Non-Current Liabilities |
270,000,000.00 |
| Sub-Total of Non-Current Liabilities |
10,677,063,549.37 |
| Total Liabilities |
14,243,285,314.21 |
| Paid-In Capital(Or Share Stock) |
2,050,769,509.00 |
| Capital Surplus |
2,788,957,506.62 |
| Surplus Reserve |
1,005,994,776.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,729,423,703.79 |
| Minority Stockholder's Interest |
15,099,468.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,575,145,496.40 |
| Owner's Equity（Stockholder's Equity） |
10,590,244,965.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,833,530,279.26 |
